GLP-1 dose changes: what titration means and who decides
Titration means a clinician adjusts a medicine’s dose step by step to balance benefit and tolerability. For GLP-1 medicines, your prescriber decides when and whether to change your dose. This page explains why schedules exist and what to bring to the conversation. It does not give a schedule, and it does not tell you what to do with your own pen.
Sources checked against Europe PMC abstracts and FDA/DailyMed label text: Nov 17, 2026; full text not read for abstract-only claims (recheck on publication date)
Quick answer
Titration means a clinician adjusts a medicine’s dose step by step to balance benefit and tolerability. For GLP-1 medicines, your prescriber decides when and whether to change your dose. This page explains why schedules exist and what to bring to the conversation. It does not give a schedule, and it does not tell you what to do with your own pen.
Why schedules exist
Weight-management labels for these medicines start at a low dose and raise it in steps. The Wegovy label says to follow its escalation table “to reduce the risk of gastrointestinal adverse reactions,” and says that if a dose is not tolerated during escalation, delaying escalation may be considered. The Zepbound label says the same purpose for its schedule, and notes that treatment response and tolerability are considered when choosing a maintenance dose. The exact steps, their length and the maximum dose are in each product’s label, and they differ by product and use. Sources: Wegovy label; Zepbound label.
A 2025 joint advisory from four U.S. nutrition and obesity societies (consensus for clinicians, not a trial) adds that gradual escalation helps the body adjust and that gastrointestinal side effects are more likely during initiation or dose escalation. It does not replace the current label or an individual prescribing decision; this page gives no alternative titration schedule. Source: joint advisory.
What the trials show about dose and tolerability

Zepbound tolerability by dose level
In the Zepbound weight-reduction trials, 4.8%, 6.3% and 6.7% of people on the 5 mg, 10 mg and 15 mg maintenance dose levels stopped because of adverse reactions, compared with 3.4% on placebo. Most stops happened in the first few months, mainly for gastrointestinal reactions. Source: Zepbound label, section 6.1. This is a group result. It does not say which dose suits any individual.
What to track around a change
- The date of each dose and of any change, and any missed or late dose.
- Symptoms and when they started relative to the dose: nausea, vomiting, diarrhea, constipation, stomach pain.
- Appetite and what you were able to eat.
- Fluids you were able to drink, and signs of dehydration such as very little urine or dizziness.
- Weight and other measurements your clinician asked for.
- All other medicines and supplements.
Do not self-adjust
Do not change, skip, split or add to your doses on your own, and do not use another person’s schedule. If a dose is missed, delayed or poorly tolerated, use the instructions in your product’s label and Medication Guide and ask your care team. The right answer depends on the product, the dose and how long it has been. This page cannot give it.
What this does not establish
The trial figures describe groups. Label schedules are for the labeled products and uses, and do not apply to compounded or other products. Nothing here says which dose, or how quickly to move, is right for you.
FAQs
What should I discuss with my clinician about GLP-1 dose changes? How you feel on the current dose, side effects and their timing, appetite and hydration, your goals, and what the plan is if side effects occur.
What information should I track or bring to the appointment? The list above.
Where can I find the instructions for my exact medicine? The label and Medication Guide for your exact product (for example Wegovy or Zepbound), the Instructions for Use that came with it, and your pharmacist.